Lone Peak Global Investors LLC Purchases 10,226 Shares of Chemed Corporation $CHE

Lone Peak Global Investors LLC raised its position in Chemed Corporation (NYSE:CHE) by 38.1% in the 2nd quarter, HoldingsChannel reports. The fund owned 37,099 shares of the company’s stock after purchasing an additional 10,226 shares during the period. Chemed makes up about 2.4% of Lone Peak Global Investors LLC’s investment portfolio, making the stock its 25th biggest holding. Lone Peak Global Investors LLC’s holdings in Chemed were worth $17,279,000 as of its most recent SEC filing.

Other hedge funds also recently modified their holdings of the company. Monetary Solutions Ltd acquired a new stake in shares of Chemed during the 4th quarter worth approximately $25,000. Los Angeles Capital Management LLC acquired a new position in shares of Chemed in the fourth quarter valued at $26,000. BOK Financial Private Wealth Inc. bought a new position in Chemed in the fourth quarter worth $27,000. Mitsubishi UFJ Asset Management Co. Ltd. bought a new position in Chemed in the second quarter worth $34,000. Finally, Versant Capital Management Inc boosted its stake in Chemed by 7,500.0% during the second quarter. Versant Capital Management Inc now owns 76 shares of the company’s stock worth $35,000 after buying an additional 75 shares in the last quarter. Institutional investors own 95.85% of the company’s stock.

Analyst Ratings Changes

CHE has been the subject of a number of recent research reports. Oppenheimer increased their price objective on shares of Chemed from $500.00 to $590.00 and gave the company an “outperform” rating in a research note on Friday, July 31st. Royal Bank Of Canada lifted their target price on shares of Chemed from $436.00 to $548.00 and gave the company a “sector perform” rating in a research report on Thursday, July 30th. Wall Street Zen raised shares of Chemed from a “hold” rating to a “strong-buy” rating in a research note on Saturday, August 1st. Bank of America reissued a “neutral” rating on shares of Chemed in a research report on Wednesday, July 29th. Finally, Weiss Ratings upgraded shares of Chemed from a “hold (c-)” rating to a “hold (c)” rating in a research note on Friday, July 17th. One equities research analyst has rated the stock with a Buy rating and five have given a Hold rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $530.75.

Chemed Price Performance

Shares of CHE stock opened at $515.96 on Wednesday. The stock’s fifty day simple moving average is $512.52 and its 200 day simple moving average is $450.53. Chemed Corporation has a one year low of $365.20 and a one year high of $557.00. The firm has a market cap of $6.74 billion, a price-to-earnings ratio of 25.91, a P/E/G ratio of 1.96 and a beta of 0.51. The company has a debt-to-equity ratio of 0.17, a current ratio of 0.91 and a quick ratio of 0.89.

Chemed (NYSE:CHE) last released its quarterly earnings data on Tuesday, July 28th. The company reported $6.06 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.60 by $0.46. The firm had revenue of $673.25 million during the quarter, compared to analyst estimates of $665.04 million. Chemed had a return on equity of 31.77% and a net margin of 10.60%.The business’s revenue for the quarter was up 8.8% compared to the same quarter last year. During the same period in the prior year, the company posted $4.27 earnings per share. Chemed has set its FY 2026 guidance at 25.000-25.750 EPS. On average, analysts expect that Chemed Corporation will post 23.18 earnings per share for the current fiscal year.

Chemed Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, September 3rd. Investors of record on Monday, August 17th will be issued a dividend of $0.70 per share. The ex-dividend date of this dividend is Monday, August 17th. This represents a $2.80 annualized dividend and a yield of 0.5%. This is an increase from Chemed’s previous quarterly dividend of $0.60. Chemed’s payout ratio is 14.06%.

Insider Activity

In other Chemed news, Director Patrick P. Grace sold 190 shares of the company’s stock in a transaction dated Friday, July 31st. The shares were sold at an average price of $532.00, for a total transaction of $101,080.00. Following the sale, the director directly owned 3,533 shares of the company’s stock, valued at approximately $1,879,556. This represents a 5.10% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Kevin J. Mcnamara sold 2,000 shares of the firm’s stock in a transaction that occurred on Monday, August 3rd. The stock was sold at an average price of $539.51, for a total transaction of $1,079,020.00. Following the sale, the chief executive officer directly owned 70,418 shares of the company’s stock, valued at approximately $37,991,215.18. The trade was a 2.76% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 6,537 shares of company stock valued at $3,406,014 in the last ninety days. 3.33% of the stock is currently owned by corporate insiders.

Chemed Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.